Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Capital and Business Alliance with Aillis, Inc. and Acquisition of Shares through Third-Party Allocation of New Shares.
TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes
TAUNS Laboratories, First Half Ordinary Profit Increases by 11%, Oct-Dec Ordinary Profit Increases by 30%
Financial Highlights for 2Q ended December 31, 2024
Financial Results for the SIX Months Ended December 31, 2024 (Japanese Accounting Standards)
Notice of Strategic Business Alliance with ZACROS Corporation
Patent on Method and Reagent for Detecting Target Substance Granted in Japan
(Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
Notice regarding Preparation for Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
TAUNS Laboratories,Inc., July-September (1Q) Ordinary Profit Increases by 0.3%
Supplementary Material on Financial Results for the Three Months Ended September 30, 2024
Financial Results for the Three Months Ended September 30, 2024 (Japanese Accounting Standards)
Announcement of Participation in the Triple I for Global Health (Impact Investment Initiative for Global Health)
Announcement of Conclusion of License Agreement with First Screening Corp.
Announcement of Acquisition of "Kurumin" Certification as a Child-Rearing Support Company
Notice of Personnel Changes